Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
34.08
+0.06 (0.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
Legend Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 | 2019 - 2018 |
| Net Income | -348.13 | -518.25 | -446.35 | -403.58 | -266.37 | -101.59 | Upgrade
|
| Depreciation & Amortization | 19.87 | 18.53 | 15.92 | 12.54 | 9.74 | 5.2 | Upgrade
|
| Other Amortization | 2.05 | 1.92 | 2.48 | 1.38 | 4.21 | 0.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.23 | 0.48 | 0.97 | 0.06 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.13 | -0.66 | -0.59 | - | -0.05 | -0.47 | Upgrade
|
| Stock-Based Compensation | 68.14 | 47.68 | 34.34 | 20.16 | 4.76 | 1.27 | Upgrade
|
| Other Operating Activities | 10.37 | 128.61 | 5.24 | 8.15 | 45.44 | -37.3 | Upgrade
|
| Change in Accounts Receivable | 0.29 | -98.98 | 50.32 | 24.59 | -45 | 21.23 | Upgrade
|
| Change in Inventory | -14.65 | -12.71 | -13.89 | 0.05 | -0.64 | -0.02 | Upgrade
|
| Change in Accounts Payable | 9.58 | -12.7 | 25.85 | 1.81 | -4.35 | 2.01 | Upgrade
|
| Change in Unearned Revenue | 100.11 | 100.02 | 6.18 | 0.08 | 2.45 | - | Upgrade
|
| Change in Other Net Operating Assets | -5.36 | -46.96 | 118.75 | 135.39 | 26.75 | 26.55 | Upgrade
|
| Operating Cash Flow | -157.6 | -393.28 | -201.28 | -198.47 | -223.01 | -83.07 | Upgrade
|
| Capital Expenditures | -16.07 | -20.08 | -20.93 | -42.2 | -26.25 | -26.77 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | 0 | 0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.5 | -2.64 | -1.35 | -3.21 | -4.03 | -0.53 | Upgrade
|
| Investment in Securities | -273.8 | 204.58 | -41.36 | -147.88 | 25.56 | -69.55 | Upgrade
|
| Other Investing Activities | -62.82 | -89.07 | -13.45 | -1.71 | -19.45 | 38.13 | Upgrade
|
| Investing Cash Flow | -355.19 | 92.79 | -77.09 | -194.98 | -24.17 | -58.65 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 41.81 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 41.81 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0 | -22.09 | Upgrade
|
| Long-Term Debt Repaid | - | -3.76 | -2.6 | -1.42 | -2.6 | -5.06 | Upgrade
|
| Total Debt Repaid | -2.78 | -3.76 | -2.6 | -1.42 | -2.61 | -27.15 | Upgrade
|
| Net Debt Issued (Repaid) | -2.78 | -3.76 | -2.6 | -1.42 | -2.61 | 14.67 | Upgrade
|
| Issuance of Common Stock | 9.73 | 795.25 | 380.57 | 628.08 | 463.55 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | -2.51 | - | Upgrade
|
| Financing Cash Flow | 6.96 | 791.49 | 377.98 | 626.66 | 618.88 | 14.67 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.64 | 0.68 | -2.51 | 0.03 | 0.62 | 0.25 | Upgrade
|
| Net Cash Flow | -504.19 | 491.68 | 97.09 | 233.25 | 372.33 | -126.8 | Upgrade
|
| Free Cash Flow | -173.67 | -413.36 | -222.21 | -240.66 | -249.26 | -109.84 | Upgrade
|
| Free Cash Flow Margin | -33.39% | -144.97% | -189.91% | -349.67% | -332.35% | -177.73% | Upgrade
|
| Free Cash Flow Per Share | -0.95 | -2.35 | -1.40 | -1.71 | -2.11 | -1.10 | Upgrade
|
| Cash Interest Paid | 1.54 | 1.39 | 0.53 | 0.14 | 0.2 | 0.22 | Upgrade
|
| Cash Income Tax Paid | 0.59 | -0.31 | -3.71 | -0.56 | -7.11 | 15.43 | Upgrade
|
| Levered Free Cash Flow | -120.41 | -441.19 | -202.66 | -122.84 | -169.98 | -111.38 | Upgrade
|
| Unlevered Free Cash Flow | -106.48 | -427.57 | -195.91 | -122.28 | -169.86 | -111.24 | Upgrade
|
| Change in Net Working Capital | -41.57 | 196.6 | -59.92 | -135.32 | 14.62 | 7.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.